Due to significant variability among tumors and diversity in human immune types, developing immunotherapies for cancer is challenging. In a study published online in iGenome Research/i, researchers examined the largest collection of tumor samples to date to predict patient-specific tumor mutations that may activate the patient's immune system, paving the way for more successful, personalized cancer immunotherapy. Tumor cells accrue mutations in ...
Read MoreYou have just read an article categorized health
titled Immunogenic Mutations in Tumor Genomes Linked to Successful Cancer Immunotherapy.
Written by:
editor - Wednesday, April 30, 2014
There are currently no comments for "Immunogenic Mutations in Tumor Genomes Linked to Successful Cancer Immunotherapy"
Post a Comment